Diabetes Drugs
- All
- News
- Videos
-
Rising Diabetes In US Kids: Can Mounjaro Be The Answer? New Study Says Yes
A new study reveals Mounjaro may help children as young as 10 manage Type 2 diabetes, significantly reducing blood sugar and weight, with Eli Lilly pushing to expand its use beyond adults.
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
AI Revolutionising Fight Against Cancer And Diabetes
AI in drug discovery Artificial intelligence is rapidly transforming the way new drugs and therapeutic targets are discovered in cancer immunology.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Boy, Diagnosed With Typhoid, Prescribed Drugs To Treat Diabetes, Heart Issue In Maharashtra
A ten-year-old boy, who was diagnosed with typhoid and pneumonia, was prescribed medicines used in the treatment of type 2 diabetes and heart-related chest pain (angina) in Maharashtra's Kalyan, close to Mumbai.
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
Weight Loss Ad Sparks Controversy: "Don't Promote Obesity, It's A lifestyle Disease," Say Experts
Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver and others.
-
Mounjaro: Everything You Need To Know About This Medication
Read on as we discuss everything you need to know about this medication.
-
Nature's Ozempic? Scientists Uncover Potential Weight Loss Solution
Scientists have discovered a gut microbe and its metabolites that can naturally regulate blood sugar levels and sugar cravings, potentially replacing weight loss drugs like Ozempic with a natural alternative.
-
Eli Lilly Launches Weight Loss Drug In India: What You Should Know About Mounjaro
Mounjaro for Weight Loss: By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and weight.
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
Biocon Launches Diabetes, Obesity Management Drug In UK
Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.
-
Rising Diabetes In US Kids: Can Mounjaro Be The Answer? New Study Says Yes
A new study reveals Mounjaro may help children as young as 10 manage Type 2 diabetes, significantly reducing blood sugar and weight, with Eli Lilly pushing to expand its use beyond adults.
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
AI Revolutionising Fight Against Cancer And Diabetes
AI in drug discovery Artificial intelligence is rapidly transforming the way new drugs and therapeutic targets are discovered in cancer immunology.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Boy, Diagnosed With Typhoid, Prescribed Drugs To Treat Diabetes, Heart Issue In Maharashtra
A ten-year-old boy, who was diagnosed with typhoid and pneumonia, was prescribed medicines used in the treatment of type 2 diabetes and heart-related chest pain (angina) in Maharashtra's Kalyan, close to Mumbai.
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
Weight Loss Ad Sparks Controversy: "Don't Promote Obesity, It's A lifestyle Disease," Say Experts
Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver and others.
-
Mounjaro: Everything You Need To Know About This Medication
Read on as we discuss everything you need to know about this medication.
-
Nature's Ozempic? Scientists Uncover Potential Weight Loss Solution
Scientists have discovered a gut microbe and its metabolites that can naturally regulate blood sugar levels and sugar cravings, potentially replacing weight loss drugs like Ozempic with a natural alternative.
-
Eli Lilly Launches Weight Loss Drug In India: What You Should Know About Mounjaro
Mounjaro for Weight Loss: By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and weight.
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
Biocon Launches Diabetes, Obesity Management Drug In UK
Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.
